Thermo Fisher Scientific
TMO
2,388 hedge funds and large institutions have $178B invested in Thermo Fisher Scientific in 2023 Q2 according to their latest regulatory filings, with 148 funds opening new positions, 922 increasing their positions, 956 reducing their positions, and 124 closing their positions.
19% more first-time investments, than exits
New positions opened: 148 | Existing positions closed: 124
0% more funds holding
Funds holding: 2,386 → 2,388 (+2)
4% less repeat investments, than reductions
Existing positions increased: 922 | Existing positions reduced: 956
9% less capital invested
Capital invested by funds: $196B → $178B (-$18.3B)
10.56% less ownership
Funds ownership: 100% → 89.44% (-11%)
12% less call options, than puts
Call options by funds: $1.16B | Put options by funds: $1.31B
34% less funds holding in top 10
Funds holding in top 10: 214 → 141 (-73)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMCA
Arthur M. Cohen & Associates
Northbrook,
Illinois
|
+$1.68B |
| 2 |
TCI Fund Management
London,
United Kingdom
|
+$1.26B |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$987M |
| 4 |
PG
Prostatis Group
Hanover,
Maryland
|
+$782M |
| 5 |
Morgan Stanley
New York
|
+$420M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIAM
OFI Invest Asset Management
Paris,
France
|
-$21.8B |
| 2 |
WEG
World Equity Group
Schaumburg,
Illinois
|
-$2.2B |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.16B |
| 4 |
Jennison Associates
New York
|
-$858M |
| 5 |
BlackRock
New York
|
-$744M |
TMO Hedge Fund Activity: Q2 2023 in Review
2,388 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2023, worth a combined $178B — down 9.3% from $196B a quarter earlier.
Buyers outnumbered sellers: 148 funds opened new TMO positions and 124 closed out — a net gain of 24 holders — while 922 added to existing stakes and 956 trimmed.
The largest buyer was Arthur M. Cohen & Associates, adding an estimated $1.68B. The largest seller was OFI Invest Asset Management, cutting an estimated $21.8B.
- 2,388 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2023, up from 2,386 in Q1 2023.
- Funds reported $178B of Thermo Fisher Scientific stock for Q2 2023, down 9.3% quarter-over-quarter.
- 148 funds opened new Thermo Fisher Scientific positions in Q2 2023 and 124 closed out, a net change of +24 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2023 was Arthur M. Cohen & Associates, an estimated $1.68B added.
- The largest Thermo Fisher Scientific seller in Q2 2023 was OFI Invest Asset Management, an estimated $21.8B sold.
Based on aggregated 13F filings for Q2 2023.